Eye Health and Treatment: An Evidence-Based Appraisal of Floaters, Dry Eye, and Macular Degeneration

The Evidence-Based Truth About Eye Health and Treatment

Bottom line

Most “eye health” claims cannot be translated directly from an ingredient, proposed mechanism, or personal experience into a therapeutic effect. The clearest current benefits of supplements apply only to specific populations with macular degeneration; other interventions should be judged individually according to diagnosis, strength of evidence, and risk. PMID: 37702300

Floaters: pineapple and enzymes are still not established treatments

Professor Lin's central objections to the claim that “eating pineapple dissolves floaters” included the lack of controls in early research, uncertainty over whether orally consumed enzymes can reach the vitreous, and the inability to explain why an enzyme would act only on floating opacities even if it did reach the eye. A later placebo-controlled trial of a combination enzyme product did report positive results. As the science has evolved, it is therefore no longer accurate to say that this entire line of research contains no controlled study. However, that trial did not test pineapple alone and remains insufficient to establish efficacy; independent replication and mechanistic evidence are still lacking. PMID: 36431188 PMID: 42245557

The experience of floaters is highly subjective, and a patient's reported severity does not necessarily correspond to visible vitreous opacity. Without a suitable control, natural variation, attention, and gradual adaptation may all be mistaken for an effect of food. PMID: 39458005 PMID: 42344255

A sudden, marked change in floaters should not be self-assessed with food remedies. There is currently no direct clinical evidence for the causal claim that ordinary eye-rolling causes retinal detachment. By contrast, the degree of myopia and axial length are risk factors with a stronger basis in the literature. PMID: 29478194 PMID: 42480650

Dry eye: lack of conclusive evidence does not mean every treatment is ineffective

Results in dry-eye research often depend on disease subtype, formulation, endpoint, and follow-up method. Reliable systematic reviews find that conclusive evidence of benefit remains unavailable for multiple interventions. This means that certainty is insufficient, not that every therapy has been proven ineffective. PMID: 38127364

Marine fish oil did not reduce the incidence of dry eye in a large randomized trial, and its effect on existing dry-eye symptoms has not produced a consistent, clinically meaningful conclusion. Other meta-analyses have found positive signals, so the more accurate statement is that the evidence is inconsistent. Patients and clinicians may assess actual response and risk together, but should not claim universal benefit. PMID: 35679030 PMID: 31847055 PMID: 29652551 PMID: 38002640

Randomized-trial evidence now exists for electrical stimulation, an area in which the literature has been updated. Yet short-term measures cannot be extrapolated into a claim of a “complete cure,” and a study of limb blood flow in rats certainly cannot directly demonstrate efficacy for human dry eye. PMID: 41933265 PMID: 28549566

Macular degeneration and cataracts: formulations have defined boundaries of use

The key evidence for antioxidant-and-zinc formulations concerns people who already have macular degeneration and face a higher risk of progression. It cannot be rewritten as support for preventive use by every healthy person. In people without macular degeneration, antioxidant supplements have not been shown to prevent onset; in those with the condition, benefits must still be assessed according to disease stage and formulation. PMID: 28756617 PMID: 37702300

Lutein and zeaxanthin from foods or supplements can indeed affect measures related to macular pigment, but a change in a marker is not the same as curing an eye disease. Meta-analyses published as the science evolved also mean that the proposition “supplementation may be worthwhile only in more advanced disease” should no longer be applied indiscriminately. This is an update to the evidence landscape, not a rewriting of Professor Lin's historical position as though he personally adopted a later claim. PMID: 42028334

Antioxidant vitamins cannot be claimed to prevent, delay, or eliminate cataracts. Although gac fruit can alter blood nutrient concentrations, that finding is not human evidence that it treats cataracts, glaucoma, or macular degeneration. PMID: 22696344 PMID: 11976161

Lutein and β-carotene may compete during intestinal absorption, but research has not shown that taking them together adversely affects medium-term blood concentrations, nor has it established an interaction that should always be considered contraindicated. At the same time, the relevant large trials were not specifically designed to prove “the complete absence of any interaction”; citations must remain within the boundaries of the question studied. PMID: 11864859 PMID: 23644932

In selenium-sufficient regions, a randomized trial did not show that selenium supplementation improved quality of life or clinical parameters in mild-to-moderate Graves eye disease. The absence of a particular risk from a guideline also cannot, by itself, establish that the risk does not exist. PMID: 40014353 PMID: 29376219

Dietary nitrate was once associated with a lower risk of macular-degeneration progression, but the association disappeared after adjustment for overall dietary patterns; this finding cannot support a nitrate-treatment recommendation. Coffee studies must likewise distinguish genetic inference from cross-sectional association. Even if differences in retinal measures are observed, they do not directly prove that coffee prevents or causes macular degeneration. PMID: 36547942 PMID: 40521080 PMID: 36904194

Anthocyanins and exaggerated advertising

Rigorous research does not support the claim that bilberry anthocyanins improve normal night vision in healthy people. Later small trials have produced possible signals involving vision or visual fatigue, reflecting an update in the literature, but these studies remain small, heterogeneous, and largely short-term. They are not sufficient to support routine recommendations for all anthocyanin products. PMID: 14711439 PMID: 41515122

If a product study measures only oxidation-related markers and skin appearance, it cannot be retold as proof that the product affects “youth genes,” much less extended into claims of improving floaters, cognitive ability, or rejuvenating multiple organs. PMID: 19954332

Blue light, ultraviolet radiation, and lenses

Blue-light-filtering lenses have not been shown to produce a clear improvement in short-term eye strain or visual acuity. However, studies have not adequately tested macular health, and any sleep benefit remains uncertain; the absolute assertion that they have “no effect whatsoever” therefore goes too far. PMID: 37593770

Blue light from smartphones at night may affect melatonin and sleep, and advice to avoid light-emitting devices before bedtime has an evidentiary basis. That is a different proposition from claiming that smartphone blue light inevitably and directly causes eye disease. PMID: 38846535

Ultraviolet radiation from sunlight is associated with pterygium, cataracts, and other ocular damage, so blocking ultraviolet radiation has a reasonable protective purpose. Whether long-term, low-intensity visible blue light causes age-related eye disease in humans should, at present, remain uncertain. PMID: 30241306 PMID: 42068868

The darkening and fading of photochromic lenses are affected by ambient temperature; this is an optical property. It does not itself prove that reducing visible blue light prevents retinal damage. PMID: 32470032 PMID: 37593770

New technologies and surgery: ask first about clinical evidence and the definition of success

Claims that an implanted lens can rapidly deliver extraordinary vision, remain effective for life, and cause no adverse effects cannot bypass peer review, clinical trials, and approval requirements for high-risk medical devices. Current reviews still do not support any technology as simultaneously restoring accommodation, remaining effective over the long term, and producing no adverse effects. PMID: 41517464 PMID: 40261654

Surgery that uses a tooth as a support for an artificial cornea is intended for severe ocular-surface disease when other operations have failed; it does not turn a tooth into an eye. Anatomical retention, functional vision, and complications also represent different definitions of success and cannot be reduced to a single success rate. PMID: 41501589 PMID: 22330056